Symbols

Symbols

ADIL

ADIL News

Newswire

10:46

Adial Pharma Announces 1-for-25 Reverse Stock Split to Regain Nasdaq Compliance, Shares Plummet 20%

09:37

Adial Pharmaceuticals Welcomes Congressional Directive to Advance Alternative Clinical Trial Endpoints for Substance Use Disorders, Enhancing Regulatory Path for AD04 Therapy.

06:27

Adial Pharmaceuticals shares rise 19.56% premarket after U.S. Senate supports expanded clinical trial endpoints beyond abstinence in alcohol and substance use disorder treatments.

09:03

Adial Pharmaceuticals CEO Cary Claiborne on Big Biz Show.

09:02

Adial Pharmaceuticals CEO Featured on The Big Biz Show

About ADIL

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction